| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |